Skip to main content

Kidney Injury clinical trials at UCSF

1 research study open to eligible people

Kidney injury is when your kidneys are harmed or damaged. UCSF is studying how mild COVID-19 affects kidney injury in patients who aren't in the hospital. This research is part of the KIDney Injury in Times of COVID-19 (KIDCOV) trial.

Showing trials for
  • KIDney Injury in Times of COVID-19 (KIDCOV)

    open to eligible people ages 18 years and up

    There is an unmet need to evaluate the impact of sub-clinical/mild COVID19 disease in the outpatient setting on prevalent and incident renal injury, as this data is currently unavailable. To capture the diversity of race/ethnic risk and COVID19 related municipal shelter-in-place guidance, the investigators will enroll COVID19-negative and COVID19-positive samples balanced by race/ethnicity from 3 different states, California, Michigan, and Illinois. Study endpoints will be assayed from urine samples mailed to the study team at 2, 6, and 12 months after their date of PCR test, with no requirement for these individuals to leave their homes to participate.

    San Francisco, California and other locations

Our lead scientists for Kidney Injury research studies include .

Last updated: